PT - JOURNAL ARTICLE AU - Tuhina Neogi AU - Tim L Th A Jansen AU - Nicola Dalbeth AU - Jaap Fransen AU - H Ralph Schumacher AU - Dianne Berendsen AU - Melanie Brown AU - Hyon Choi AU - N Lawrence Edwards AU - Hein J E M Janssens AU - Frédéric Lioté AU - Raymond P Naden AU - George Nuki AU - Alexis Ogdie AU - Fernando Perez-Ruiz AU - Kenneth Saag AU - Jasvinder A Singh AU - John S Sundy AU - Anne-Kathrin Tausche AU - Janitzia Vaquez-Mellado AU - Steven A Yarows AU - William J Taylor TI - 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative AID - 10.1136/annrheumdis-2015-208237 DP - 2015 Oct 01 TA - Annals of the Rheumatic Diseases PG - 1789--1798 VI - 74 IP - 10 4099 - http://ard.bmj.com/content/74/10/1789.short 4100 - http://ard.bmj.com/content/74/10/1789.full SO - Ann Rheum Dis2015 Oct 01; 74 AB - Objective Existing criteria for the classification of gout have suboptimal sensitivity and/or specificity, and were developed at a time when advanced imaging was not available. The current effort was undertaken to develop new classification criteria for gout.Methods An international group of investigators, supported by the American College of Rheumatology and the European League Against Rheumatism, conducted a systematic review of the literature on advanced imaging of gout, a diagnostic study in which the presence of monosodium urate monohydrate (MSU) crystals in synovial fluid or tophus was the gold standard, a ranking exercise of paper patient cases, and a multi-criterion decision analysis exercise. These data formed the basis for developing the classification criteria, which were tested in an independent data set.Results The entry criterion for the new classification criteria requires the occurrence of at least one episode of peripheral joint or bursal swelling, pain, or tenderness. The presence of MSU crystals in a symptomatic joint/bursa (ie, synovial fluid) or in a tophus is a sufficient criterion for classification of the subject as having gout, and does not require further scoring. The domains of the new classification criteria include clinical (pattern of joint/bursa involvement, characteristics and time course of symptomatic episodes), laboratory (serum urate, MSU-negative synovial fluid aspirate), and imaging (double-contour sign on ultrasound or urate on dual-energy CT, radiographic gout-related erosion). The sensitivity and specificity of the criteria are high (92% and 89%, respectively).Conclusions The new classification criteria, developed using a data-driven and decision-analytic approach, have excellent performance characteristics and incorporate current state-of-the-art evidence regarding gout.